Trial Profile

An Open-Label, Non-Randomised, Single-Dose, Single-Period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of 14C-AB1010 in Healthy Male Subjects

Status: Completed

Phase of Trial: Phase 0

Latest Information Update: 27 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Masitinib (Primary)
Indications Alzheimer's disease; Amyotrophic lateral sclerosis; Asthma; Breast cancer; Chronic obstructive pulmonary disease; Colorectal cancer; COVID 2019 infections; Crohn's disease; Gastrointestinal stromal tumours; Glioblastoma; Head and neck cancer; Liver cancer; Malignant melanoma; Mastocytosis; Multiple myeloma; Multiple sclerosis; Non-small cell lung cancer; Oesophageal cancer; Ovarian cancer; Pancreatic cancer; Parkinson's disease; Peripheral T-cell lymphoma; Progressive supranuclear palsy; Prostate cancer; Psoriasis; Rheumatoid arthritis; Stroke
Focus Pharmacokinetics
Sponsors AB Science

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com